Literature DB >> 11711775

A monoclonal antibody that recognizes a potential coeliac-toxic repetitive pentapeptide epitope in gliadins.

A A Osman1, H H Uhlig, I Valdes, M Amin, E Méndez, T Mothes.   

Abstract

OBJECTIVES: Antibodies that detect coeliac-toxic prolamins from wheat, barley and rye are important tools for controlling the diet of coeliac disease patients. Recently, a monoclonal antibody R5 that recognizes wheat gliadin, barley hordein and rye secalin equally was described. In this study, the epitope recognized by R5 was investigated.
METHODS: Both a phage-displayed heptapeptide library and overlapping peptides spanning the sequence of alpha- and gamma-type gliadins (pepscan) were screened for binding of R5.
RESULTS: Both techniques yielded comparable pentapeptide consensus sequences (phage display QXPW/FP; pepscan QQPFP). According to recent observations, this peptide stretch may be of key importance in the pathogenicity of coeliac disease. This sequence occurs repetitively in prolamins (in gamma- and omega-type prolamins more frequently than in alpha-type prolamins) together with several homologous peptide stretches, which are recognized less strongly.
CONCLUSIONS: R5 seems to be a good candidate for the specific detection of putative coeliac disease-active sequences in prolamins and thus represents a valuable tool for the quality control of gluten-free food.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711775     DOI: 10.1097/00042737-200110000-00011

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  20 in total

1.  Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein.

Authors:  Dominique Bétemps; Jérémy Verchère; Anne-Laure Mougenot; Ingolf Lachmann; Eric Morignat; Emilie Antier; Latifa Lakhdar; Stéphane Legastelois; Thierry Baron
Journal:  J Vis Exp       Date:  2015-05-30       Impact factor: 1.355

2.  Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.

Authors:  Na Tian; Guoxian Wei; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

3.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

4.  Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease.

Authors:  Guoxian Wei; Na Tian; Adriana C Valery; Yi Zhong; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Gastroenterol       Date:  2015-04-21       Impact factor: 10.864

5.  Monoclonal antibodies as diagnostics; an appraisal.

Authors:  M Z Siddiqui
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

6.  Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease.

Authors:  Guoxian Wei; Na Tian; Roland Siezen; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-28       Impact factor: 4.052

7.  Consumption of pure oats by individuals with celiac disease: a position statement by the Canadian Celiac Association.

Authors:  Mohsin Rashid; Decker Butzner; Vernon Burrows; Marion Zarkadas; Shelley Case; Mavis Molloy; Ralph Warren; Olga Pulido; Connie Switzer
Journal:  Can J Gastroenterol       Date:  2007-10       Impact factor: 3.522

8.  Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.

Authors:  Na Tian; Daniel A Leffler; Ciaran P Kelly; Joshua Hansen; Eric V Marietta; Joseph A Murray; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-01       Impact factor: 4.052

9.  Efficient chemo-enzymatic gluten detoxification: reducing toxic epitopes for celiac patients improving functional properties.

Authors:  Miguel Ribeiro; Fernando M Nunes; Sofia Guedes; Pedro Domingues; Amélia M Silva; Jose Maria Carrillo; Marta Rodriguez-Quijano; Gérard Branlard; Gilberto Igrejas
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

10.  Identification of novel antibody-reactive detection sites for comprehensive gluten monitoring.

Authors:  Niels Röckendorf; Barbara Meckelein; Katharina A Scherf; Kathrin Schalk; Peter Koehler; Andreas Frey
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.